Literature DB >> 15055516

The conversion challenge: from intrathecal to oral morphine.

Robert K Sylvester1, Stephanie M Lindsay, Caroline Schauer.   

Abstract

Numerous articles have described the methodologies used and outcomes achieved with the intrathecal (IT) administration of morphine for pain. However, only one case report has been published that describes converting a patient's IT morphine to an oral regimen. This case report describes the experience of converting a patient's IT morphine to oral morphine and discusses the scarcity of published data to validate suggested equianalgesic intraspinal morphine recommendations. The calculated equianalgesic oral to IT ratio in this case was 12:1. This is substantially lower than the 300:1 ratio published by Krames and the 90:1 ratio employed by a commercially available software program for calculating equianalgesic opioid doses. We recommend caution when applying existing guidelines for conversion of morphine from an IT to an oral regimen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15055516     DOI: 10.1177/104990910402100214

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  8 in total

1.  A hospice-based advanced pharmacy experience.

Authors:  Robert K Sylvester; Joanna Roberg; Wanda Roden; Karen Smithson
Journal:  Am J Pharm Educ       Date:  2009-05-27       Impact factor: 2.047

2.  Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note.

Authors:  Haocheng Zhou; Dong Huang; Dingquan Zou; Junjiao Hu; Xinning Li; Yaping Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 3.  Intrathecal pumps.

Authors:  Shawn Belverud; Alon Mogilner; Michael Schulder
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

4.  Ceasing intrathecal therapy in chronic non-cancer pain: an invitation to shift from biomedical focus to active management.

Authors:  Chris Hayes; Meredith S Jordan; Fiona J Hodson; Linda Ritchard
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

5.  Efficacy of an intrathecal multidrug infusion for pain control in older adults and in end-stage malignancies: A report of three cases.

Authors:  Sadegh Abdolmohammadi; Pierre-Olivier Hétu; Andrée Néron; Gilbert Blaise
Journal:  Pain Res Manag       Date:  2015 May-Jun       Impact factor: 3.037

Review 6.  Practical considerations and patient selection for intrathecal drug delivery in the management of chronic pain.

Authors:  Michael Saulino; Philip S Kim; Erik Shaw
Journal:  J Pain Res       Date:  2014-11-10       Impact factor: 3.133

7.  Survey of pain specialists regarding conversion of high-dose intravenous to neuraxial opioids.

Authors:  Andrew W Gorlin; David M Rosenfeld; Jillian Maloney; Christopher S Wie; Johnathan McGarvey; Terrence L Trentman
Journal:  J Pain Res       Date:  2016-09-21       Impact factor: 3.133

8.  Evaluation of an Intrathecal Drug Delivery Protocol Leads to Rapid Reduction of Systemic Opioids in the Oncological Population.

Authors:  Matthew A Spiegel; Grant H Chen; Antonio C Solla; Lee P Hingula; Aron Legler; Amitabh Gulati
Journal:  J Palliat Med       Date:  2020-07-08       Impact factor: 2.947

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.